Tirz (Research Grade) – Dual GIP/GLP-1 Receptor Agonist for Metabolic, Insulin & Weight-Regulation Studies
Tirz is a research-grade dual GIP/GLP-1 receptor agonist used in advanced laboratory studies involving metabolic regulation, insulin sensitivity, glucose control, and weight-related pathways. Its dual-agonist mechanism allows researchers to examine how incretin signaling influences energy balance, appetite modulation, pancreatic function, and glycemic response in controlled experimental environments.
Researchers use Tirzepatide to investigate:
Dual GIP/GLP-1 receptor activity
Insulin signaling and glucose metabolism
Appetite-regulation pathways and energy intake models
Adipose-tissue behavior and weight-management mechanisms
Metabolic-disorder research, including obesity and insulin resistance
Syans Bio Lab provides Tirz (Research Grade) with exceptional purity, stability, and reproducibility, supporting high-quality results across metabolic, endocrine, and incretin-pathway research.
For laboratory research use only. Not for human consumption. Not a drug, dietary supplement, or therapeutic agent.
Inventory: 15
Quantity: 10MG , 20MG

